These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16217388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats.
    Yokoyama O, Yusup A, Oyama N, Aoki Y, Tanase K, Matsuta Y, Miwa Y, Akino H.
    Neurourol Urodyn; 2006; 25(5):461-7. PubMed ID: 16673377
    [Abstract] [Full Text] [Related]

  • 3. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
    Hedlund P, Streng T, Lee T, Andersson KE.
    J Urol; 2007 Jul; 178(1):326-31. PubMed ID: 17507042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
    Kim Y, Yoshimura N, Masuda H, De Miguel F, Chancellor MB.
    BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
    Angelico P, Velasco C, Guarneri L, Sironi G, Leonardi A, Testa R.
    BMC Pharmacol; 2005 Oct 11; 5():14. PubMed ID: 16216132
    [Abstract] [Full Text] [Related]

  • 10. Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.
    Yokoyama O, Yusup A, Oyama N, Aoki Y, Miwa Y, Akino H.
    J Urol; 2007 Feb 11; 177(2):771-5. PubMed ID: 17222679
    [Abstract] [Full Text] [Related]

  • 11. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y, Nishiguchi J, Kwon DD, Chancellor MB, Arai Y, Snyder PB, Yoshimura N.
    BJU Int; 2008 Mar 11; 101(5):615-20. PubMed ID: 18070178
    [Abstract] [Full Text] [Related]

  • 12. Antidiuretic effect of antimuscarinic agents in rat model depends on C-fibre afferent nerves in the bladder.
    Watanabe N, Akino H, Kurokawa T, Taga M, Yokokawa R, Tanase K, Nagase K, Yokoyama O.
    BJU Int; 2013 Jul 11; 112(1):131-6. PubMed ID: 23432937
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats.
    Yokoyama O.
    Neurourol Urodyn; 2010 Jul 11; 29(1):107-11. PubMed ID: 20025014
    [Abstract] [Full Text] [Related]

  • 14. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C.
    BJU Int; 2012 Jul 11; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [Abstract] [Full Text] [Related]

  • 15. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity.
    Aizawa N, Igawa Y, Andersson KE, Iijima K, Nishizawa O, Wyndaele JJ.
    Neurourol Urodyn; 2011 Jan 11; 30(1):163-8. PubMed ID: 20665548
    [Abstract] [Full Text] [Related]

  • 16. The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.
    Boy S, Schurch B, Mehnert U, Mehring G, Karsenty G, Reitz A.
    BJU Int; 2007 Sep 11; 100(3):574-8. PubMed ID: 17669142
    [Abstract] [Full Text] [Related]

  • 17. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
    Suzuki M, Ohtake A, Yoshino T, Yuyama H, Hayashi A, Ukai M, Okutsu H, Noguchi Y, Sato S, Sasamata M.
    Eur J Pharmacol; 2005 Apr 04; 512(1):61-6. PubMed ID: 15814091
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents.
    Nagabukuro H, Villa KL, Wickham LA, Kulick AA, Gichuru L, Donnelly MJ, Voronin GO, Pereira T, Tong X, Nichols A, Alves SE, O'Neill GP, Johnson CV, Hickey EJ.
    J Pharmacol Exp Ther; 2011 Jul 04; 338(1):220-7. PubMed ID: 21459965
    [Abstract] [Full Text] [Related]

  • 19. Antimuscarinic effects on current perception threshold: a prospective placebo control study.
    Vijaya G, Digesu GA, Derpapas A, Hendricken C, Fernando R, Khullar V.
    Neurourol Urodyn; 2012 Jan 04; 31(1):75-9. PubMed ID: 22038939
    [Abstract] [Full Text] [Related]

  • 20. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
    Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N.
    J Urol; 2001 Mar 04; 165(3):975-9. PubMed ID: 11176525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.